NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $378,920 | +0.9% | 3,720 | 0.0% | 0.10% | +6.5% |
| Q2 2023 | $375,386 | +9.7% | 3,720 | 0.0% | 0.09% | +4.5% |
| Q1 2023 | $342,240 | +1.4% | 3,720 | 0.0% | 0.09% | -2.2% |
| Q4 2022 | $337,478 | +19.3% | 3,720 | 0.0% | 0.09% | +11.0% |
| Q3 2022 | $283,000 | -15.0% | 3,720 | -5.7% | 0.08% | -11.8% |
| Q2 2022 | $333,000 | -3.8% | 3,943 | 0.0% | 0.09% | +14.8% |
| Q1 2022 | $346,000 | +0.3% | 3,943 | -0.0% | 0.08% | +5.2% |
| Q4 2021 | $345,000 | +1.8% | 3,944 | -4.8% | 0.08% | -8.3% |
| Q3 2021 | $339,000 | -10.3% | 4,143 | 0.0% | 0.08% | -13.4% |
| Q2 2021 | $378,000 | +4.1% | 4,143 | -2.4% | 0.10% | -2.0% |
| Q1 2021 | $363,000 | -12.1% | 4,243 | -3.0% | 0.10% | -16.1% |
| Q4 2020 | $413,000 | +14.4% | 4,373 | +5.4% | 0.12% | +2.6% |
| Q3 2020 | $361,000 | -0.3% | 4,150 | 0.0% | 0.12% | -7.3% |
| Q2 2020 | $362,000 | +4.6% | 4,150 | -1.1% | 0.12% | -7.5% |
| Q1 2020 | $346,000 | -12.8% | 4,195 | 0.0% | 0.13% | +3.9% |
| Q4 2019 | $397,000 | -32.6% | 4,195 | -38.1% | 0.13% | -29.5% |
| Q3 2019 | $589,000 | -3.6% | 6,779 | +1.3% | 0.18% | +5.2% |
| Q2 2019 | $611,000 | -7.8% | 6,694 | -2.9% | 0.17% | -13.9% |
| Q1 2019 | $663,000 | +12.0% | 6,894 | 0.0% | 0.20% | -1.0% |
| Q4 2018 | $592,000 | -4.5% | 6,894 | -4.1% | 0.20% | +4.1% |
| Q3 2018 | $620,000 | +1.3% | 7,192 | -11.2% | 0.20% | -4.4% |
| Q2 2018 | $612,000 | -11.0% | 8,098 | -4.8% | 0.20% | +35.8% |
| Q1 2018 | $688,000 | -6.4% | 8,508 | -2.8% | 0.15% | +5.6% |
| Q4 2017 | $735,000 | +7.8% | 8,754 | +10.2% | 0.14% | -0.7% |
| Q3 2017 | $682,000 | +1.6% | 7,944 | -1.2% | 0.14% | -2.0% |
| Q2 2017 | $671,000 | +5.8% | 8,044 | -5.8% | 0.15% | -3.3% |
| Q1 2017 | $634,000 | -6.4% | 8,538 | -8.1% | 0.15% | -14.6% |
| Q4 2016 | $677,000 | -15.4% | 9,292 | -8.3% | 0.18% | -23.6% |
| Q3 2016 | $800,000 | -6.4% | 10,137 | -2.1% | 0.23% | -20.2% |
| Q2 2016 | $855,000 | +11.6% | 10,357 | -2.0% | 0.29% | -23.0% |
| Q1 2016 | $766,000 | -42.9% | 10,570 | -32.2% | 0.38% | -49.8% |
| Q4 2015 | $1,341,000 | -9.8% | 15,582 | -3.6% | 0.76% | -15.5% |
| Q3 2015 | $1,487,000 | -3.1% | 16,168 | +3.7% | 0.89% | -2.7% |
| Q2 2015 | $1,534,000 | -2.1% | 15,593 | -1.8% | 0.92% | -3.3% |
| Q1 2015 | $1,567,000 | +4.4% | 15,886 | -2.0% | 0.95% | +8.1% |
| Q4 2014 | $1,501,000 | – | 16,206 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |